Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 1djn | ADP | Trimethylamine dehydrogenase | 1.5.8.2 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 1djn | ADP | Trimethylamine dehydrogenase | 1.5.8.2 | 1.000 | |
| 1djq | ADP | Trimethylamine dehydrogenase | 1.5.8.2 | 0.898 | |
| 2tmd | ADP | Trimethylamine dehydrogenase | 1.5.8.2 | 0.775 | |
| 1o94 | ADP | Trimethylamine dehydrogenase | 1.5.8.2 | 0.609 | |
| 1w4x | FAD | Phenylacetone monooxygenase | 1.14.13.92 | 0.478 | |
| 4b69 | FAD | L-ornithine N(5)-monooxygenase | / | 0.478 | |
| 4bk3 | FAD | Probable salicylate monooxygenase | / | 0.474 | |
| 3cge | FAD | Coenzyme A disulfide reductase | / | 0.473 | |
| 2zzc | FAD | Thioredoxin reductase 1, cytoplasmic | 1.8.1.9 | 0.469 | |
| 4ntd | FAD | Thioredoxin reductase | / | 0.467 | |
| 3k30 | ADP | Histamine dehydrogenase | / | 0.463 | |
| 1ges | FAD | Glutathione reductase | 1.8.1.7 | 0.461 | |
| 4tlx | FDA | KtzI | / | 0.461 | |
| 2yls | FAD | Phenylacetone monooxygenase | 1.14.13.92 | 0.459 | |
| 3f8r | NAP | NADH oxidase/thioredoxin reductase | / | 0.459 | |
| 1x7d | NAD | Putative ornithine cyclodeaminase | / | 0.457 | |
| 2ch6 | ADP | N-acetyl-D-glucosamine kinase | 2.7.1.59 | 0.457 | |
| 2zz0 | FAD | Thioredoxin reductase 1, cytoplasmic | 1.8.1.9 | 0.456 | |
| 3fpz | AHZ | Thiamine thiazole synthase | / | 0.454 | |
| 2c3c | FAD | 2-oxopropyl-CoM reductase, carboxylating | 1.8.1.5 | 0.453 | |
| 2c3d | FAD | 2-oxopropyl-CoM reductase, carboxylating | 1.8.1.5 | 0.453 | |
| 2ylz | FAD | Phenylacetone monooxygenase | 1.14.13.92 | 0.451 | |
| 3s5w | FAD | L-ornithine N(5)-monooxygenase | / | 0.451 | |
| 2bry | FAD | [F-actin]-methionine sulfoxide oxidase MICAL1 | 1.14.13 | 0.448 | |
| 3uox | FAD | 2-oxo-Delta(3)-4,5,5-trimethylcyclopentenylacetyl-CoA monooxygenase | 1.14.13.160 | 0.447 | |
| 3uoy | FAD | 2-oxo-Delta(3)-4,5,5-trimethylcyclopentenylacetyl-CoA monooxygenase | 1.14.13.160 | 0.447 | |
| 2rcy | NAP | Pyrroline-5-carboxylate reductase | / | 0.446 | |
| 2yr4 | FAD | Phenylalanine 2-monooxygenase precursor | 1.13.12.9 | 0.446 | |
| 4opi | FDA | Conserved Archaeal protein | / | 0.446 | |
| 4is3 | NAD | 3alpha-hydroxy bile acid-CoA-ester 3-dehydrogenase 2 | 1.17.98.1 | 0.445 | |
| 4tm0 | FAD | KtzI | / | 0.445 | |
| 2gew | FAD | Cholesterol oxidase | 1.1.3.6 | 0.443 | |
| 4g9k | FAD | Rotenone-insensitive NADH-ubiquinone oxidoreductase, mitochondrial | 1.6.5.9 | 0.443 | |
| 4y9q | C2E | Uncharacterized protein | / | 0.443 | |
| 3wv7 | ADP | Hmd co-occurring protein HcgE | / | 0.441 | |
| 2q0l | FAD | Thioredoxin reductase | 1.8.1.9 | 0.440 | |
| 2qo5 | CHD | Fatty acid-binding protein 10-A, liver basic | / | 0.440 | |
| 4c7k | NAP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.440 | |
| 5jla | NAD | Putative short-chain dehydrogenase/reductase | / | 0.440 |